Tools and resources

1 Purpose of this document

1 Purpose of this document

NICE's assessment of digital technologies for delivering weight-management services to manage weight-management medicine recommends that more evidence is generated for 5 technologies (Gro Health W8Buddy, Liva, Oviva, Roczen, and Second Nature) while they are being used in the NHS. Three other technologies can only be used in research and are not covered in this plan.

This plan outlines the evidence gaps and what real-world data needs to be collected for a NICE review of the technologies again in the future. It is not a study protocol but suggests an approach to generating the information needed to address the evidence gaps.

The company is responsible for ensuring that data collection and data analysis takes place. Support for evidence generation will be available through a competitive process facilitated by the Office for Life Sciences, pending business case approval. This will be in the form of funding for evidence generation consortia, bringing analytical partners and implementation sites together with developers for evidence generation.

The Department of Health and Social Care's Office for Health Improvement and Disparities has also announced a 2-year pilot programme evaluating service delivery models to support access to weight-management medicine. NHS England will deliver the programme, with analytical partners commissioned by the National Institute for Health and Care Research. The programme may support evidence generation for technologies adopted through NHS England's procurement process.

Guidance on commissioning and procurement of the technologies will be provided by NHS England, who are developing a digital health technology policy framework to further outline commissioning pathways.

NICE will withdraw the early value assessment guidance if the technology developers do not meet the conditions in section 4 of this evidence generation plan on monitoring.

After the end of the evidence generation period (4 years), the companies should submit the evidence to NICE in a form that can be used for decision making. NICE will review all the evidence and assess whether the technologies can be routinely adopted in the NHS.


This page was last updated: